Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2012

View Archived Issues

Candidate AIDS drug active against resistant HIV-1

Baicalein induces cancer cell death via autophagy

Dutch study reveals potential biomarker for Alzheimer's disease

COMP issues opinion on Albireo's lead hepatology candidate

Halo Healthcare signs agreement with the University of North Dakota

DNDi and Cipla join forces to develop combination drug for pediatric HIV

Ironwood Pharmaceuticals presents novel FAAH inhibitors

Pharminox reports new candidate cancer therapies

GlaxoSmithKline gets priority review for Promacta sNDA

EntreMed kicks off single-agent trial in triple-negative breast cancer

Novel bacterial extracts disclosed by Pierre Fabre Medicament

Merck Serono obtains priority review for Erbitux application

Researchers at Biotica Technology patent new sanglifehrin derivatives

New disease-modifying candidate drug for Alzheimer's disease targets FLN-A

New protein kinase inhibitors synthesized at Sanofi

Mesoblast product shuts down multiple cytokine pathways in arthritis model

NIH-funded trial to test vaginal ring for HIV prevention in women

FDA clears IND application for ImmunoCellular Therapeutics cancer vaccine

Karyopharm Therapeutics product enters clinical testing

Leo Pharma divulges novel ingenol derivatives

Roche designs novel JAK1 inhibitors

Sanofi Pasteur reports on tetravalent dengue vaccine study

FDA grants fast track status to IDX-719

International collaboration uncovers link between key brain functions and dementia

CytRx begins trial of aldoxorubicin/doxorubicin combination

Potential treatment for advanced Alzheimer's disease enters clinic

NICE issues final guidance on Xarelto use for DVT treatment and prevention

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...